This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 1-7 May 2022 and includes updates on COVID-19, Influenza, the arrival of people displaced from Ukraine to the EU following Russia's invasion of Ukraine, hepatitis, Ebola, Middle East respiratory syndrome coronavirus, chikungunya and dengue.
This document provides an overview of public health guidance aimed to ensure that the needs of refugees in relation to viral hepatitis are appropriately met, for all stages along the continuum of care from prevention through to treatment.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 24-30 April 2022 and includes updates on COVID-19, Influenza, the arrival of people displaced from Ukraine to the EU following Russia's invasion of Ukraine, hepatitis, Ebola, cholera and poliomyelitis.
This report presents the results of the ECDC European Reference Laboratory Network for Pertussis (ERLNPert-Net) external quality assessment (EQA) scheme for Bordetella pertussis PCR, funded by ECDC on behalf of ERLNPert-Net and conducted from April to September 2020. The EQA was organised by the National Institute for Biological Standards and Control (NIBSC), based in Potter’s Bar, United Kingdom (UK).
An increase in severe acute hepatitis cases of unknown aetiology among previously healthy children was first reported by the United Kingdom (UK) on 5 April 2022.
Following the initial report of an increase of severe acute hepatitis cases of unknown aetiology among previously healthy children by the United Kingdom on 5 April 2022, and as of 20 April 2022, 111 cases, aged 10 and under have been identified in that country.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 17-23 April 2022 and includes updates on COVID-19, Influenza, the arrival of people displaced from Ukraine to the EU following Russia's invasion of Ukraine, hepatitis and poliomyelitis.
Following the reports of cases of acute hepatitis of unknown origin by the UK Health Security Agency, additional cases in children have been reported in Denmark, Ireland, the Netherlands, and Spain.